IDEX BIOMETRICS ASA [CBOE] overview

Reference is made to IDEX Biometrics ASA’s announcement on 14 April 2025 regarding a notice of large shareholding. By inadvertence, the announcement contained some minor errors in the shareholders name and new number of shares. Please see correct notification below: IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a...

IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. A close associate of Robert Keith, Charles Street Holding Ltd, will, subject to the registration of the...

IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. Altea AS will, subject to the registration of the share capital reduction, be allocated 287,500,000 shares in...

IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. Sundt AS, subject to the registration of the share capital reduction, will be allocated 200,000,000 shares in...

IDEX Biometrics ASA discloses the following on behalf of a shareholder. Reference is made to the notice by IDEX Biometrics on 11 April 2025 that the Extraordinary General Meeting of the company had, subject to the registration of a share capital reduction, resolved to issue 3,000,000,000 shares in a debt conversion, thereby increasing the number of shares in the company to 3,831,594,232. Anders Storbråten, subject to the registration of the share capital reduction, will be allocated 862,500,000...

IDEX Biometrics ASA informs of primary insider transactions as listed in the attached notifications. For further information contact: Marianne Bøe, Head of Investor Relations, Tel: +47 91800186 Kristian Flaten, CFO, Tel: +47 95092322 E-mail: [email protected] This information is subject to the disclosure requirements pursuant to Article 19 of the EU Market Abuse Regulation and Section 5-12 of the Norwegian Securities Trading Act. Attachments 2025-04-11 Morten Opstad Chairman Primary Insider...

Reference is made to the Extraordinary General Meeting in IDEX Biometrics ASA ("IDEX" or the "Company") on 11 April 2025, where all proposed resolutions were approved. Key information relating to the approved share consolidation: Date on which the terms and conditions of the share consolidation was made public: 11 April 2025; Share consolidation ratio: 100 old shares give 1 new share; Last day including right: 10 June 2025; Ex-date: 11 June 2025; Record date: 12 June 2025; and Date of approval:...

IDEX Biometrics ASA held an extraordinary general meeting on 11 April 2025. 268,077,252 million shares or 32.24 % of the capital was represented at the meeting. All resolutions were passed as proposed in the notice of the meeting, including the share capital reduction and the share consolidation, with an update as regards to the dates in item 5 on the agenda regarding the Subsequent offering and the date of the share consolidation in item 8 on the agenda. The share consolidation of a hundred...